Stock Quote (NASDAQ: NSTG)
Price:
19.26
Change:
- 0.51
Day High:
19.88
Day Low:
19.19
Volume:
166,069
4:00 PM ET on Sep 23, 2016
Delayed at least 20 minutes.
Provided by eSignal.


Search Investor Relations

Press Releases

All Releases
View Summary PRESS RELEASESep 13, 2016
NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors
read more
View Summary PRESS RELEASEAug 25, 2016
NanoString Technologies to Present at Two Upcoming Healthcare Conferences
read more
View Summary PRESS RELEASEAug 03, 2016
NanoString Technologies Releases Operating Results for Second Quarter of 2016
read more
View Summary PRESS RELEASEJul 07, 2016
NanoString Technologies to Release Second Quarter 2016 Financial Results and Host Conference Call on Wednesday, August 3, 2016
read more
View Summary PRESS RELEASEJun 02, 2016
NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
read more
View Summary PRESS RELEASEMay 26, 2016
Cigna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay
read more
View Summary PRESS RELEASEMay 24, 2016
NanoString Technologies to Present at the Jefferies 2016 Healthcare Conference
read more
View Summary PRESS RELEASEMay 09, 2016
Aetna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay
read more
View Summary PRESS RELEASEMay 05, 2016
NanoString Technologies Releases Operating Results for First Quarter of 2016
read more
View Summary PRESS RELEASEApr 27, 2016
NanoString Technologies to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
read more
View Summary PRESS RELEASEApr 18, 2016
NanoString Technologies Presents Proof-of-Concept Data for Multiplexed Digital IHC in Tumor Tissues at AACR Meeting
read more
View Summary PRESS RELEASEApr 14, 2016
NanoString Technologies Unveils New nCounter Vantage™ Assays to Power Cancer Research With 3D Biology™
read more
View Summary PRESS RELEASEApr 13, 2016
NanoString Technologies to Release First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5, 2016
read more
View Summary PRESS RELEASEApr 11, 2016
NanoString Technologies and HalioDx Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology
read more
View Summary PRESS RELEASEMar 21, 2016
NanoString Technologies Receives Favorable Final Local Coverage Determination by Noridian Healthcare Solutions for Its Prosigna Breast Cancer Assay
read more
View Summary PRESS RELEASEMar 10, 2016
NanoString Technologies and Cell Signaling Technology Announce Agreement to Expand Suite of 3D Biology Assays
read more
View Summary PRESS RELEASEFeb 29, 2016
NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook
read more
View Summary PRESS RELEASEFeb 29, 2016
NanoString Technologies and Merck Expand Collaboration to Develop and Commercialize Novel Diagnostic Test to Predict Response to KEYTRUDA® (pembrolizumab)
read more
View Summary PRESS RELEASEFeb 22, 2016
NanoString Technologies to Present at the Cowen and Company 36th Annual Health Care Conference
read more
View Summary PRESS RELEASEFeb 12, 2016
NanoString Technologies to Release Fourth Quarter 2015 Financial Results and Host Conference Call on Monday, February 29, 2016
read more
Showing 1-20 of 163 Page: 1 2 3 4 5 ... 9  Next 20